Brief: Gensight Biologics Completes A 30 Million Euros Capital Increase

Gensight Biologics SA

26/03/2021 06:42

March 26 (Reuters) - Gensight Biologics SA  SIGHT.PA :
    * GENSIGHT BIOLOGICS SUCCESSFULLY RAISES €30 MILLION IN AN
OVERSUBSCRIBED PRIVATE PLACEMENT WITH EUROPEAN AND US
INSTITUTIONAL INVESTORS
    * COMPANY HAS ISSUED 4,477,612 NEW ORDINARY SHARES WITH A
NOMINAL
VALUE OF EUR 0.025 EACH
    * TOTAL GROSS PROCEEDS OF APPROXIMATELY EUR 30 MILLION
    * BOOK WAS LARGELY OVERSUBSCRIBED, BASED ON DEMAND FROM NEW
INVESTORS
    * ISSUE PRICE OF NEW SHARES IS EUR 6.70 PER SHARE,
REPRESENTING A
9.0% DISCOUNT TO LAST CLOSING SHARE PRICE
    * FOLLOWING ISSUANCE OF NEW SHARES, COMPANY'S TOTAL SHARE
CAPITAL
WILL BE EUR 1,149,431.93

Source text for Eikon:  ID:nBw4SSk15a 
Further company coverage:  SIGHT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))